14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $16.55 $18.63 Wednesday, 24th Apr 2024 ACAD stock ended at $16.59. This is 0.90% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 1.72% from a day low at $16.55 to a day high of $16.84.
90 days $16.55 $27.94
52 weeks $16.55 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Sep 19, 2023 $24.62 $24.67 $24.05 $24.44 1 825 245
Sep 18, 2023 $24.71 $25.09 $24.18 $24.42 1 890 481
Sep 15, 2023 $25.88 $25.88 $24.67 $24.72 1 766 895
Sep 14, 2023 $25.97 $26.58 $25.62 $25.85 1 272 080
Sep 13, 2023 $26.08 $26.38 $25.64 $25.89 1 316 460
Sep 12, 2023 $27.13 $27.13 $25.91 $26.14 1 087 250
Sep 11, 2023 $26.45 $27.18 $26.22 $27.13 1 171 241
Sep 08, 2023 $26.29 $26.68 $26.23 $26.45 631 240
Sep 07, 2023 $26.91 $26.92 $26.29 $26.34 741 242
Sep 06, 2023 $27.57 $27.65 $26.97 $27.11 784 352
Sep 05, 2023 $27.65 $27.82 $27.14 $27.57 838 107
Sep 01, 2023 $27.17 $27.86 $27.17 $27.79 827 756
Aug 31, 2023 $26.99 $27.38 $26.86 $27.02 1 120 612
Aug 30, 2023 $27.17 $27.50 $26.90 $26.99 1 039 929
Aug 29, 2023 $27.87 $27.87 $26.77 $27.09 1 419 938
Aug 28, 2023 $28.56 $28.66 $27.80 $27.87 1 023 955
Aug 25, 2023 $28.52 $28.83 $28.17 $28.60 748 454
Aug 24, 2023 $28.74 $28.81 $28.26 $28.40 885 108
Aug 23, 2023 $29.14 $29.35 $28.59 $28.64 882 569
Aug 22, 2023 $30.30 $30.31 $29.06 $29.09 940 503
Aug 21, 2023 $29.33 $30.49 $28.75 $30.32 1 896 694
Aug 18, 2023 $28.60 $29.50 $28.49 $29.33 1 187 033
Aug 17, 2023 $29.23 $29.26 $28.66 $28.90 1 739 911
Aug 16, 2023 $29.06 $29.99 $28.92 $29.25 2 020 956
Aug 15, 2023 $28.07 $28.74 $27.76 $28.72 1 205 512
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT